Compare MIRA & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIRA | KXIN |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | China |
| Employees | N/A | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 9.3M |
| IPO Year | 2023 | N/A |
| Metric | MIRA | KXIN |
|---|---|---|
| Price | $0.95 | $6.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 99.7K | ★ 411.8K |
| Earning Date | 05-13-2026 | 11-26-2019 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.90 | $0.11 |
| 52 Week High | $2.45 | $22.00 |
| Indicator | MIRA | KXIN |
|---|---|---|
| Relative Strength Index (RSI) | 41.69 | 64.23 |
| Support Level | $0.91 | $0.44 |
| Resistance Level | $1.24 | $7.06 |
| Average True Range (ATR) | 0.04 | 0.52 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 24.72 | 95.54 |
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Kaixin Holdings is an auto dealership company mainly engaged in the sale of domestic and imported automobiles in China. The company provides new and used car buyers in China with access to a wide selection of used vehicles across its network of dealerships, with a focus on premium brands such as Audi, BMW, Mercedes-Benz, Land Rover, and Porsche. The company generates revenue from automobile sales and related services.